Free Research Reports on ASTM, FRO, LCC and LNDC Issued by the Bedford Report Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

© Marketwire 2013
28.03.2013 14:26:01 -

( - NEW YORK, NY -- (Marketwire) -- 03/28/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Aastrom Biosciences, Inc. (NASDAQ: ASTM) shares plunged 38.25 percent on volume of over 4 million shares traded Wednesday to close at $0.71 a share. The company announced that it has stopped enrollment and will end the Phase 3 REVIVE clinical trial in patients with critical limb ischemia. Aastrom also plans to reduce its workforce and operating expenses by approximately 50 percent.

Find out more about Aastrom Biosciences including full access to the free equity report at: :

Frontline Ltd. (NYSE: FRO) shares gained 11.82 percent on volume of nearly 2.0 million shares traded Wednesday to close at $2.46 a share. The company reported a net loss of $16.6 million for the fourth quarter of 2012, compared to a net loss of $49.0 million for the preceding quarter.

Find out more about Frontline including full access to the free equity report at: :

US Airways Group, Inc. (NYSE: LCC) shares have gained over 22 percent year-to-date. US Airways merger with American Airlines parent AMR Corp. received court approval on Wednesday. The global airline industry is expected to see profits of $10.6 billion in 2013, according to the International Air Transport Association.

Find out more about US Airways Group including full access to the free equity report at: :

Landec Corporation (NASDAQ: LNDC) shares fell sharply in early trading Wednesday before recovering to close at $13.63 a share, an increase of 2.17 percent. The company reported revenues of $117.9 million for the fiscal third quarter, an increase of 47 percent when compared to the year ago quarter.

Find out more about Landec including full access to the free equity report at: :

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact :


Disclaimer: (c) 2015 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
refer this article
Print This Article